HIBT Lab! Immunai: Noam Solomon

HIBT Lab! Immunai: Noam Solomon

‏التالي

Advice Line with Jeffrey Hollender of Seventh Generation

Today’s callers: Kristina in Ohio looks for avenues beyond organic social media to market her furniture designed for toddlers and parents alike. Then Phil in Michigan considers the best messaging to brew interest in his farm-made cherry vinegar. And Caroline in California scouts ...  عرض المزيد

Justin’s Nut Butter: Justin Gold. He Was Waiting Tables, Then...He Reinvented Peanut Butter.

At 25, Justin Gold was making experimental peanut butter in his home kitchen with a food processor and a stack of recipe journals. His singular obsession: bring new life to a tired lunchtime staple.What started as late-night experiments with honey, cinnamon and banana eventually ...  عرض المزيد

‏حلقات موصى بها

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
NVIDIA AI Podcast

What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI ...  عرض المزيد

A New Drug For A Relentless Brain Disease
Short Wave

ALS is a disease that destroys the nerve cells in the brain and spinal cord we need for voluntary movement. There is no cure, but now there is a newly approved medication that may slow down the disease and extend patients' lives. The drug, called Relyvrio, got its start with a co ...  عرض المزيد

Battling Pathogens and Building Immunity Begins In Your Gut – Dr. Robynne Chutkan : 998
The Human Upgrade: Biohacking for Longevity & Performance

IN THIS EPISODE OF THE HUMAN UPGRADE™… Robynne Chutkan, M.D., joins the show to talk about a topic that’s foundational to biohacking—resilience. More specifically, resilience that starts in the gut. You’ll learn:

<ul><li>how your microbiome continually ...  عرض المزيد

Antibiotics: How to fix a broken market
Business Daily

Antibiotics stopped providing big gains for pharmaceutical companies decades ago, but as bacteria become more resistant to drugs, the world needs new classes of antibiotics to be discovered if we want to prevent the next global health crisis.Dr Tina Joshi, Associate Professor of ...  عرض المزيد